| CPC G16B 20/20 (2019.02) [C12Q 1/6869 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/6886 (2013.01); G06F 40/174 (2020.01); G16B 30/00 (2019.02); G16H 15/00 (2018.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01)] | 23 Claims |
|
1. An analysis method of analyzing a nucleic acid sequence of a patient sample with a computer, comprising:
sequencing a tumor cell collected from a patient to create first nucleic acid sequence data;
sequencing a non-tumor cell collected from the patient to create second nucleic acid sequence data;
obtaining the first nucleic acid sequence data, and the second nucleic acid sequence data;
detecting a somatic mutation based on analyzing the first nucleic acid sequence data;
detecting a germline mutation based on analyzing the second nucleic acid sequence data;
selecting a presentation form for presenting information on the germline mutation of the patient among different candidate forms for presenting analysis reports for the patient; and
creating an analysis report for the patient in the selected presentation form, wherein
the candidate forms comprise a first form that presents the analysis report in a form that excludes at least part of the information on the germline mutation of the patient and a second form that presents the analysis report in a form that includes the information on the germline mutation of the patient; and
selecting the presentation form comprises selecting among the first form and the second form based on a selection criteria that indicates a permissible presentation form of the information on the germline mutation.
|